![Riamilovir sodium hydrate - CAS# 928659-17-0 60175 [Epub ahead of print] PubMed](https://cdn.shopify.com/s/files/1/0389/1897/9723/products/Riamilovir_sodium_hydrate.jpg?v=1742673037)
Pay in 4 interest-free payments of $6.25 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
[Epub ahead of print] PubMed PMID: 27655223
PubMed PMID: 28474758
PF-04494700
HLY78 acts synergistically with Wnt in the embryonic development of zebrafish and increases the expression of the conserved hematopoietic stem cell (HSC) markers
10 µM KGN in 4 µl of saline was intra-articularly (IA) delivered into mice on days 7 and 21 in the collagenase VII–induced model and the acute surgical model
Riamilovir sodium hydrate - CAS# 928659-17-0 60175 [Epub ahead of print] PubMedRiamilovir sodium hydrate, CAS No. 928659 17 0, also known as Triazavirin, is an antiviral drug candidate. Tiazavirin is a broad spectrum antiviral drug developed in Russia. It has a novel triazolotriazine core, which represents a new structural class of non nucleoside antiviral drugs. It was originally developed as a potential treatment for pandemic influenza strains such as H5N1, and most of the testing that has been done has focused on its anti